Miloš Ćorlomanović
From Wikipedia, the free encyclopedia
Miloš Ćorlomanović (Serbian Cyrillic: Милош Ћорломановић; born September 14, 1982, in Pančevo) is Serbian – Chinese scientist, whose origin is Serbian. He lives and works both in Serbia and China. He is an engineer of electrical engineering and a Doctor of physics, a specialist in biophysics, an competent in NMR and an expert for EMP technologies.[3][4][5][6][9][10][11][12][13][14][15][16][17][18][19][20][21][22]
Miloš Ćorlomanović | |
---|---|
Milos M. Ćorlomanović | |
Born | September 14, 1982 |
Nationality | Serb |
Citizenship | Serbia |
Education | Technical School Smederevo, Higher Technical School Smederevo, University of Belgrade, University of Western Australia |
Known for | Biomar device,[1] Discovery in the field of detection of complex signal from liquid water[2][3][4][5][6][7] |
Awards | Academician[8] |
Scientific career | |
Fields | Theoretical and experimental physics, biophysics, electrical engineering, biomedicine, bioengineering |
Institutions | Institute of Natural Sciences Lunchang Chinese Academy of Sciences |
He is a member of Institute of Natural Sciences Lunchang (pinyin Longcheng),[8][23][24] Beijing University, Chinese Academy of Sciences with a title of academician and a director of the ININT laboratory (Institute for Advanced Research Nikola Tesla).[25][26]
His researches relates to electronics, physics, biophysics, biomedicine, bioengineering, hydrology, energetics, aeronautics and cosmonautics, as well as to quantum-information technologies.
He is occupied by theoretical physics domains, especially torsion fields and quantum information theory, and has several scientistic works related to this topics.[27] He also has a few technical inventions in multidisciplinary fields and theoretical conclusions.[1] It seems that he was the first who introduced terms such as quantum information and quantum-information technology to physics.
His greatest discovery so far is the detection of a complex signal from the liquid water, which happened on August 19, 2017 in Institute for Biomedical Research and Bioengineering, in the Chinese city of Yantai, while he worked on clinical testing about influence of Quantum fields on anti -cancer drug quality improvement and also a quantum information operation to the same drug as well.[2][28][3][4][5][6][9][10][11][12][29]